113 related articles for article (PubMed ID: 7517747)
21. Drug resistance mechanisms in chronic lymphocytic leukemia.
Ribrag V; Massade L; Faussat AM; Dreyfus F; Bayle C; Gouyette A; Marie JP
Leukemia; 1996 Dec; 10(12):1944-9. PubMed ID: 8946935
[TBL] [Abstract][Full Text] [Related]
22. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ
Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079
[TBL] [Abstract][Full Text] [Related]
23. When and how to treat chronic lymphocytic leukemia.
Dighiero G; Binet JL
N Engl J Med; 2000 Dec; 343(24):1799-801. PubMed ID: 11114321
[No Abstract] [Full Text] [Related]
24. Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
Ayyildiz O; Isikdogan A; Bolaman Z; Muftuoglu E
Saudi Med J; 2004 Dec; 25(12):2054-6. PubMed ID: 15711709
[No Abstract] [Full Text] [Related]
25. [Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease].
Tumakov VA; Abdulkadyrov KM; Rugal' VI; Karpenkov MV; Ved' VV; Brodovskiĭ AF
Klin Med (Mosk); 1991 Jan; 69(1):94-7. PubMed ID: 2023411
[TBL] [Abstract][Full Text] [Related]
26. [Mantle cell lymphoma mimicking chronic lymphocytic leukemia].
Hanamura A; Hayakawa M; Naito K
Rinsho Ketsueki; 2005 Jan; 46(1):13-8. PubMed ID: 16708912
[TBL] [Abstract][Full Text] [Related]
27. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
[TBL] [Abstract][Full Text] [Related]
28. Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia.
Maďarová M; Mucha R; Hresko S; Makarová Z; Gdovinová Z; Szilasiová J; Vitková M; Guman T; Štecová N; Dobransky T
Leuk Res; 2018 Jul; 70():25-33. PubMed ID: 29763855
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
30. Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy.
Molica S; Vacca A; Tucc L; Ribatti D
Haematologica; 2005 May; 90(5):698-700. PubMed ID: 15921392
[TBL] [Abstract][Full Text] [Related]
31. Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia.
Alexandrescu DT; Wiernik PH
Med Oncol; 2008; 25(3):309-14. PubMed ID: 18176848
[TBL] [Abstract][Full Text] [Related]
32. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Robak T
Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
[TBL] [Abstract][Full Text] [Related]
33. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
34. Chronic lymphocytic leukemia--correlation of response and survival.
Keating MJ; O'Brien S; Robertson L; Huh Y; Kantarjian H; Plunkett W
Leuk Lymphoma; 1993; 11 Suppl 2():167-75. PubMed ID: 8124227
[TBL] [Abstract][Full Text] [Related]
35. [A case of B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)].
Ando S; Ando S; Otani N; Kanbe T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):153-6. PubMed ID: 8422181
[TBL] [Abstract][Full Text] [Related]
36. [Chronic lymphocytic leukemia. 2. Therapy].
Hallek M; Schmitt B; Emmerich B; Stein H
Dtsch Med Wochenschr; 2001 Jun; 126(23):690-5. PubMed ID: 11441667
[No Abstract] [Full Text] [Related]
37. Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly.
Tadmor T; Bejar J; Attias D; Polliack A
Br J Haematol; 2011 Oct; 155(2):135. PubMed ID: 21973072
[No Abstract] [Full Text] [Related]
38. B-CLL in PLL transformation associated with hypercalcemia.
Lerner D; Esteves C; De Oliveira MS
Leuk Lymphoma; 1994 Jan; 12(3-4):321-5. PubMed ID: 8167564
[TBL] [Abstract][Full Text] [Related]
39. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
[TBL] [Abstract][Full Text] [Related]
40. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]